Sirius Medical Establishes Highly Experienced Supervisory Board and Announces CEO Transition

Sirius Medical Establishes Highly Experienced Supervisory Board and Announces CEO Transition

Sirius Medical establishes highly experienced Supervisory Board and announces CEO transition

Sirius Medical establishes highly experienced Supervisory Board and announces CEO transition

Eindhoven, May 11th 2021 – Sirius Medical, a medical device start-up developing the next generation of tumor localization technology, today announced that medical device executives Jan Sigger (founder & CEO Quirem Medical) and Rob de Ree (CEO NorthSea Therapeutics) will join the Company’s Supervisory Board. The Board is further strengthened by Jan-Frens van Giessel (Partner at Holland Capital) and Hubert Martens (CEO Salvia BioElectronics; co-founder and ex-CEO Sirius Medical). Bram Schermers (co-founder of Sirius Medical) transitions to the CEO position. 

Rob de Ree

CEO NorthSea Therapeutics

Jan Sigger

CEO Quirem Medical (Terumo Corp.)

Jan Frens van Giessel

Partner Holland Capital

Hubert Martens

CEO Salvia BioElectronics
Former CEO Sirius Medical

Read more about background of the Board Members

Background on Board Members
Rob de Ree
Rob de Ree is CEO of NorthSea Therapeutics and he is a venture partner at BGV. Rob is serving on the board of Mellon Medical, previously he was the Chairman of SurgVision and Ventinova medical.

Rob started his career in pharma in 1991 in sales and marketing at the cardiovascular division of Byk Gulden. Rob joined Medtronic in 1996 where he worked in various national and international sales and marketing roles. Rob moved to Crucell where he led the licensing business after which he joined BMEYE, a startup in hemodynamic monitoring where he serves as CEO until it was sold to Edwards Lifesciences. Rob was subsequently CEO of Dezima Pharma, which was sold to Amgen in October 2015. Rob holds a MSc in pharmacy from the University of Groningen.

Jan Sigger
Jan Sigger co-founded Quirem Medical in 2013 and has since then been CEO of the company. Quirem Medical develops and commercializes radioactive microspheres based on Holmium-166 for Selective Internal Radiation Therapy (SIRT). Quirem Medical was acquired by Terumo Corporation on July 14, 2020. Terumo is a listed Japanese global leader in medical technology.

Before starting Quirem Medical, Jan held senior management positions at Royal Dutch Shell and Akzo Nobel before joining Nucletron, the global market leader in brachytherapy as CFO in 2008. Between 2008 – 2012 he was instrumental in transforming Nucletron into the fastest growing radiotherapy company and managed the sale from private equity ownership to Elekta AB in 2011.
Jan currently serves as Chairman of the Supervisory Board of OCON, a leading provider of orthopaedical services in the Netherlands and as board member of the MedTechPartners Foundation, which aims to optimize the healthcare sector in the Netherlands. He is also member of an investment committee that considers the business potential of early-stage medical ventures.

Jan-Frens van Giessel
Jan-Frens is Partner at Holland Capital focusing on medical devices and digital health investments in the Netherlands. He led successfully investment rounds of Ventinova Medical (ventilation and airway management), Prolira (delirium detection), Sirius Medical (tumor localization). In addition to Sirius Medical, he currently serves on the board of several portfolio companies of Holland Capital including HealthConnected (software platform for healthcare providers) and LivAssured (NightWatch Epilepsy Detection).

Hubert Martens
Hubert Martens is a seasoned MedTech entrepreneur. With Bram Schermers, he cofounded Sirius Medical and acted as its CEO until recently, raising funds and driving product development to regulatory approval in EU/US and early commercial launch. In addition, Martens is co-founder of Salvia BioElectronics (2017) and Sapiens Steering Brain Stimulation (2011); the latter was acquired by Medtronic for $200M in 2014. Martens holds a PhD from Leiden University and has held leadership positions at Philips and Medtronic.

Mr. de Ree brings over a decade of highly relevant industry experience as a former CEO at BMEYE (acquired by Edwards Lifesciences Corp.) and Dezima Pharma (acquired by Amgen Inc.). Mr. Sigger complements this profile with a financial leadership role at Nucletron and as a co-founder and current CEO at Quirem Medical which was recently acquired by Terumo Corp.

Mr. Sigger (Supervisory Board chair): “I have become impressed by the unique Sirius localization technology and the strong team behind it. Sirius Pintuition will bring a paradigm shift for both breast cancer patients and treating physicians. I look forward to supporting the full realization of this exciting technology for the benefit of patients around the world.”

The board is completed by Jan-Frens van Giessel, experienced MedTech investment partner at Holland Capital and Hubert Martens, one of the founders and former CEO of Sirius Medical who previously co-founded Sapiens Steering Brain Stimulation (acquired by Medtronic): “although I am transitioning away from the day-to-day operations of Sirius, I will continue to support the team through my Supervisory Board membership. With the deep market knowledge of Mr. Schermers, the experienced Sirius Medical team is very well positioned to make the next steps in its development under his leadership.”

“It’s a tremendous honor to work with such an experienced Supervisory Board”, says Mr. Schermers, newly appointed CEO of Sirius Medical, “we are at a critical juncture right now, having received both US and EU regulatory approvals for Sirius Pintuition, and steadily activating customers throughout the EU. The Supervisory Board will play a pivotal role in strategic decisions that enables Sirius Pintuition to become the global standard of care.”

About Sirius Pintuition
Sirius Medical provides surgical oncologists with a highly precise, easy-to-use, and affordable solution that contributes to an improved hospital workflow. The Sirius Pintuition Seed can be placed days to weeks in advance of surgery to mark a target tissue*. During surgery, the Sirius Pintuition Probe provides highly accurate, real-time feedback and directional guidance to the marked tissue. Using Sirius Pintuition is intuitive, the system provides millimeter accuracy and directional guidance. Sirius Pintuition has been used in over 500 procedures in six countries across Europe. The system is FDA cleared and CE-marked. *Please refer to local instructions for use

About Sirius Medical
With its roots in the Netherlands Cancer Institute, Sirius Medical was born to make things better. The Sirius Pintuition system was developed by and for surgeons addressing a clear clinical need with a solution that simply makes sense. The Sirius Pintuition system is CE marked and received FDA clearance and is currently commercially available in Western Europe. Our mission is to improve care for cancer patients by delivering unsurpassed, yet affordable solutions that enable precise and efficient surgical removal of tumors.

Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion

Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion

Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion

Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion

Amsterdam, 17 February 2021 – Digital R&D simulation software platform RheoCube has attracted an investment of over 2 million USD. This funding round, which will drive RheoCube’s global expansion, was co-led by renowned investors Holland Capital and Join Capital.

Digitalization is a hot topic in R&D departments across the globe. Current R&D processes are time consuming largely due to trial-and-error in physical labs. Reducing that costly process empowers organizations to build smarter and faster R&D cycles while speeding up time to market. 

Simulation software
RheoCube is the only digital solution to offer a multi-scale approach to simulations and predictions for complex fluids by simulating lab experiments on supercomputers. RheoCube offers browser-based experimentation, is easy to use, and R&D researchers do not need simulation modeling experience. Furthermore, clients do not need to invest in heavy compute clusters as RheoCube offers integrated cloud computing.

Prominent companies such as Givaudan, Henkel and Colgate-Palmolive have already recognized these advantages and are using RheoCube to digitize their R&D processes.

Investment for growth
RheoCube has raised this funding from Holland Capital and Join Capital. The collaboration with both investors will help to drive the development and commercialization of RheoCube.

Jurjen van Rees, CCO/COO of EAL, comments: “This joint investment by two renowned investors reflects strong confidence in RheoCube as a unique, breakthrough product. It supports us in our mission to drive a major transformation in R&D: digitalization. RheoCube is changing the game for researchers and is set to become the standard Simulation-as-a-Service solution for R&D labs”. 

Niels van Aalten, Partner Holland Capital, says: “We are looking forward to working together with this talented team. RheoCube is truly a unique product, addressing a real need for R&D departments”.

Jan Borgstaedt, Managing Partner Join Capital, says: “We are thrilled to back RheoCube, whose team of leading scientific experts has convinced us that this is a company that can revolutionize R&D. We have already had the opportunity to introduce the team to global industrial companies and it quickly became apparent that the industry is waiting for a solution just like this.”

About RheoCube
RheoCube is a cloud-based complex fluids simulation platform, designed to offer a user-friendly alternative to the physical lab approach of trial-and-error, often used for prototyping new products and for applied material research. This simulation platform was created by VC-backed Electric Ant Lab (EAL) and their founder Dr. Eric Lorenz (a renowned expert in the field of computational physics). RheoCube’s clients are primarily chemistry-focused R&D scientists in large corporations in sectors such as food, coatings, homecare, personal care, and specialty chemicals.

About Holland Capital
Over the past 40 years, Holland Capital has invested responsibly and successfully in over 140 companies. With a clear investment strategy, it is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies it invests in, with the shared goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs in the relevant growth markets. 

About Join Capital
Join Capital is a Berlin-based, early-stage VC firm investing in the European Neue Industry. With a combined experience of more than 50 years among the partners, Join focuses primarily on industrial and enterprise startups that are laying new foundations for our increasingly automated and connected world. Join’s extensive network and expertise make it a unique VC for the European industrial landscape.

Holland Capital invests in cards PLM Solutions

Holland Capital invests in cards PLM Solutions

Holland Capital invests in cards PLM Solutions

Holland Capital invests in cards PLM Solutions

Amsterdam / Best, January 22, 2021 – cards PLM Solutions, Product Lifecycle Management (PLM) solutions provider, is taking the next step towards growth through the investment of private equity firm Holland Capital. The investment ensures that the growth ambition for the coming years can be realized.

cards PLM Solutions (“cards”) is a value-added reseller and business partner of Siemens Digital Industries Software and therewith the PLM specialist in the Benelux. PLM solutions contribute to the optimization of product development and the production process. In addition to software, the company provides consultancy services supplemented with support. cards expanded its service offering in 2017 with 3D printing solutions from Ultimaker and Formlabs, a fast growing complementary market. With extensive knowledge of PLM software, 3D printing and business processes in the manufacturing industry, the company is a valued partner for clients such as ASML, Frencken, NTS, AAE, KMWE and Procter & Gamble.

Digitization of the manufacturing industry
With its range of services, cards plays an important role in the digitization of the manufacturing industry, also known as “Industry 4.0”. In addition, the collaboration between Siemens and SAP in the field of PLM and Asset Lifecycle Management (ALM) will increase the demand for integrated solutions from cards.

Investment for growth
The collaboration with Holland Capital enables cards to grow organically and through acquisitions in the Benelux and DACH region (Germany, Austria and Switzerland). In addition, there are significant synergies for cooperation with other portfolio companies of Holland Capital.

Erik Burghoorn, CEO cards: “In Holland Capital we have found a partner who can support us in professionalizing the organization and realizing our growth ambitions. They understand what entrepreneurship entails and share our vision of the market”.

Ewout Prins, Managing Partner at Holland Capital: “cards is known as the PLM specialist in the Benelux and is excellently positioned to further expand this leading position locally and internationally. We are enthusiastic to support the management team in realizing the growth ambitions”.

About cards PLM Solutions
cards was founded in 1999 and is located in Best (NL) and Genk (B). The organization specializes in digitalization of business processes and information flows within the manufacturing industry. cards mainly works for companies in automotive, aerospace, high-tech mechanical engineering, medical devices and consumer goods. Over the years the company involved into  a specialized Product Lifecycle Management (PLM) solutions provider. cards is Gold Smart Expert partner of Siemens Digital Industries Software.

About Holland Capital
Over the past 40 years, Holland Capital has invested successfully in over 140 small and medium-sized enterprises in the Netherlands. With a clear investment strategy, it focuses its activities in the attractive growth markets of Healthcare and Tech. Holland Capital’s experienced and dedicated investment team knows what doing business means. They strive for an open, long-term and professional relationship with the management teams of the enterprises Holland Capital invests in, with the shared goal of achieving growth. Holland Capital is supported by a broad network of successful healthcare and technology entrepreneurs.

Dimensys receives capital injection from Holland Capital to aid further growth

Dimensys receives capital injection from Holland Capital to aid further growth

Dimensys receives capital injection from Holland Capital to aid further growth

Dimensys receives capital injection from Holland Capital to aid further growth 

Amsterdam/’s-Hertogenbosch, January 14, 2021 – Holland Capital invests in Dimensys, a specialized SAP Partner in the field of Asset and Product Lifecycle Management (PLM).

Since its inception in 2000, Dimensys has become well-known for providing specialized process and IT consultancy for SAP Asset and PLM products. These products and services enable major organizations like ASML, ProRail, Infrabel and Heijmans to monitor their assets and deploy them more effectively. Dimensys is based in ‘s-Hertogenbosch and Antwerp. Management’s aim is to further expand its leading position in the Benelux to the DACH region (Germany, Austria and Switzerland).

Ready for Industry 4.0
According to investor Holland Capital, Dimensys is a well-positioned firm that will play a key role in the further digitization of capital-intensive businesses, also known as ‘Industry 4.0’. It is expected that the demand for specialized SAP knowledge will further increase due to the transition to ‘SAP S/4 HANA’. Holland Capital’s investment in the SAP activities will enable the organization to expand geographically and realize acquisitions in both the Benelux and the DACH region.

Alexander Haas, CEO Dimensys, about the deal: In Holland Capital, we have found a strong and strategic partner who will help us to scale up through a buy & build strategy. This will enable us to grow in the future, at both a national and international level.”

Ewout Prins, Managing Partner Holland Capital, adds: “Dimensys has a distinctive proposition when it comes to SAP Asset and Product Lifecycle Management. The company, by use of their specialist knowledge,  helps resolve complex challenges of renown parties regarding the management and exploitation of capital assets. From the perspective of Holland Capital, we see plenty of opportunities for Dimensys to grow both organically and through buy & build.

About Dimensys
Dimensys assists engineering and utility companies and discrete manufacturing to achieve operational excellence in their business processes. By making the life cycle of assets and products transparent, predictable and repeatable, Dimensys enables organizations to work more effectively. To this end, the organization uses years of experience in the knowledge domains Asset and Product Lifecycle Management, Project & Portfolio Management and Manufacturing Execution System (MES). Dimensys is certified as SAP Gold Partner, SAP Partner Center of Expertise and SAP Recognized Expertise Partner. The organization is achieving strong operating results and is experiencing few problems from the Covid-19 situation.

About Holland Capital
Over the past 40 years, Holland Capital has invested successfully in over 140 small and medium-sized enterprises in the Netherlands. With a clear investment strategy, it focuses its activities in the attractive growth markets of Healthcare and Tech. Holland Capital’s experienced and dedicated investment team knows what doing business means. They strive for an open, long-term and professional relationship with the management teams of the enterprises Holland Capital invests in, with the shared goal of achieving growth. Holland Capital is supported by a broad network of successful businesses in Healthcare and Tech.

 

Intercept is pursuing an international growth strategy with Holland Capital

Intercept is pursuing an international growth strategy with Holland Capital

Intercept is pursuing an international growth strategy with Holland Capital

Intercept is pursuing an international growth strategy with Holland Capital

Amsterdam / Zwolle, January 11, 2021 – Intercept, a leading Microsoft Cloud Solution Provider (CSP), will receive a substantial capital injection from Holland Capital. Intercept helps Independent Software Vendors (ISVs) to cloudify their applications and software. The capital injection enables the company to scale up its product development and realize its international growth ambitions.

Microsoft Country Partner of the Year 2020
Intercept has been a recognized Microsoft partner for many years andrecently won Microsoft Country Partner of the Year 2020. The Cloud Solution Provider has a full focus on Microsoft Azure and is one of the most prominent players in Europe in that area. In particular, Intercept helps independent software providers (ISVs) to transform and modernize by bringing software and applications to the Azure cloud. In addition, Intercept helps companies automating, developing and protecting software in the Microsoft Azure cloud. 

Products and services for ISVs
Through a cooperation with Holland Capital, Intercept can further expand its product and services portfolio. At the moment Intercept already delivers Azure Cloudify, Azure Datacenter transformation, Azure workspace, Managed Security Services and Automation & Development. Intercept is currently developing more products to support ISVs even further.

International growth plans
The global public cloud market has grown rapidly in recent years. Internationally, Amazon (AWS) is the market leader with 47% market share. However Microsoft (Azure) is catching up and is growing almost twice as fast as Amazon (62% vs 33% growth in 2019)*. In the Netherlands, Microsoft is already the most dominant player (56% market share), driven by the increase in the adoption and use of cloud applications, infrastructure and services (such as Microsoft 365, Microsoft Azure, PowerApps & Dynamics365). In addition, there is a rapidly increasing demand for technologies such as AI, Machine Learning and 5G, which all require a cloud infrastructure*.

Job Verhagen, CEO Intercept, says: “With Holland Capital we can scale up our product development and realize our international growth ambitions. Holland Capital has expertise in correctly positioning fast-growing companies. Therefore they are a valuable partner in this new growth phase of Intercept.

Niels van Aalten, partner Holland Capital: “Because of its unique position as the main Microsoft partner for ISVs, Intercept is a very interesting company with a lot of growth potential. We are proud to support Intercept in its growth.

About Intercept
Intercept was founded in 2013 and specializes in Microsoft Azure solutions. The Cloud Service Provider from Zwolle helps software-driven organizations to digitize and modernize their businesses. In 2017, the organization was one of the first partners in the Netherlands to achieve the status of Microsoft Azure Expert Management Service Provider, a status that only dozens of companies worldwide have. Intercept was named Microsoft Country Partner of the Year in 2020.

About Holland Capital
Over the past 40 years, Holland Capital has invested responsibly and successfully in over 140 Dutch SMEs. Supported by a clear investment strategy, it is active in the attractive growth markets of Healthcare and Technology. Its experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies it invests in, united by the goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs in the relevant growth markets.

*Bron: Gartner, https://www.gartner.com/en/newsroom/press-releases/2020-08-10-gartner-says-worldwide-iaas-public-cloud-services-market-grew-37-point-3-percent-in-2019

Holland Capital invests in Purple for international expansion of digital storytelling

Holland Capital invests in Purple for international expansion of digital storytelling

Holland Capital invests in Purple for international expansion of digital storytelling

Holland Capital invests in Purple for international expansion of digital storytelling

Amsterdam, Halfweg, 5th of January 2021 – Purple, the Amsterdam-based storytelling agency, is receiving funding from private equity provider Holland Capital. This investment will enable Purple to further develop the storytelling software Hyro while expanding and strengthening its international presence, both through organic growth and buy and build.

While the coronavirus is having an impact on us all globally, it’s also affecting sales and marketing departments at large companies. Since the start of the pandemic, companies have been forced to focus even more on digital and online channels. The online market is highly saturated and extremely competitive, and it’s difficult to gain attention of your target group. That’s why standing out from the crowd is crucial. With its new Digital Studio solution, Purple’s software Hyro offers the possibility to digitally produce large-scale and unique events.

Storytelling anywhere
Hyro provides a digital environment to which users can easily upload different types of content. The software is unique because it combines both new and existing content elements to create one compelling and interactive story. In addition, Hyro is technology-agnostic and can run on any screen or digital channel: from VR to online events, and from digital signage in the office to an immersive experience room with 360° projection. Users of the software can create and modify content independently, which reduces investments in content production (traditionally a large cost item) and increases return (ROI).

Cross-border Online Events
The newest part of the Hyro software, Digital studio, is a recording and live-stream environment. Replacing the green screen with an LED studio provides more flexibility and a more realistic and high-quality result, which can also be produced in real time. Hollywood productions like The Mandalorian are already being filmed using this technology. All content, as with other digital forms of expression, is controlled via Hyro. In this way, users can independently make their own film production without being dependent upon film crews.

‘We’re noticing a very strong demand from companies that want to accelerate and innovate even more digitally. Holland Capital is a tremendously valuable partner in our ambition to strengthen Hyro’s international market position and in realizing our international growth plans.’ Joost Rueck, Managing Director and Founder of Purple.

‘Purple’s dynamic team serves an attractive international customer base in a fast-growing market with its distinctive product. We’re delighted to be able to support Purple in its growth trajectory,’ says Ewout Prins, Managing Partner of Holland Capital.

About Purple
Purple is a digital creative agency and software company based in Amsterdam. It has developed Hyro storytelling software in order to tell their customers’ stories in an engaging and unique way. Founded in 2011, Purple has worked for major national and international clients including Honeywell, PepsiCo, SAP, Under Armour, and Microsoft. www.purple.nl

About Holland Capital
Over the past 40 years, Holland Capital has invested responsibly and successfully in over 140 Dutch SMEs. Supported by a clear investment strategy, it is active in the attractive growth markets of Healthcare and Technology. Its experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies it invests in, united by the goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs in the relevant growth markets.